| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
65,690,000 |
| Market
Cap: |
18.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.285 - $0.285 |
|
| Level
I Sector: |
Conglomerates |
| Level
II Sector: |
Conglomerates |
| Level
III Sector: |
Conglomerates |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lipocine is clinical-stage biopharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products focusing on neuroendocrine and metabolic disorders. Co. has a license agreement for the development and commercialization its product candidate, TLANDO®, an oral testosterone replacement therapy comprised of testosterone undecanoate. Co.'s additional pipeline candidates, LPCN 1148 comprising a prodrug of testosterone, testosterone laurate, for the management of decompensated cirrhosis. Co. is conducting a Phase 2 POC study in male cirrhotic subjects to evaluate the therapeutic potential of LPCN 1148 for the management of sarcopenia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-07-31 |
2025-04-29 |
2024-10-29 |
2023-10-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fogarty Krista |
Principal Accounting Officer |
• – – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
991 |
1,727 |
|
- |
|
| Patel Mahesh V. |
CEO and President |
• • – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,893 |
112,311 |
|
- |
|
| Patel Mahesh V. |
CEO and President |
• • – |
2023-05-25 |
4 |
B |
$5.03 |
$43,791 |
D/D |
8,706 |
107,418 |
2.81 |
- |
|
| Patel Mahesh V. |
CEO and President |
• • – |
2023-03-24 |
4 |
B |
$0.32 |
$48,000 |
D/D |
150,000 |
1,678,090 |
2.81 |
-4% |
|
| Ono Richard Dana |
Director |
– • – |
2023-03-20 |
4 |
B |
$0.34 |
$1,360 |
D/D |
4,000 |
14,125 |
2.31 |
-12% |
|
| Patel Mahesh V. |
CEO and President |
• • – |
2023-03-17 |
4 |
B |
$0.33 |
$16,500 |
D/D |
50,000 |
1,528,090 |
2.81 |
-18% |
|
| Papapetropoulos Spyridon |
Director |
– • – |
2022-11-22 |
4 |
B |
$0.47 |
$10,217 |
D/D |
21,739 |
21,739 |
2.39 |
-27% |
|
| Patel Mahesh V. |
CEO and President |
• • – |
2022-11-14 |
4 |
B |
$0.39 |
$29,250 |
D/D |
75,000 |
1,478,090 |
2.81 |
-14% |
|
| Patel Mahesh V. |
CEO and President |
• • – |
2022-09-27 |
4 |
B |
$0.41 |
$41,000 |
D/D |
100,000 |
1,403,090 |
2.81 |
37% |
|
| Fogarty Krista |
Principal Accounting Officer |
• – – |
2022-05-17 |
4 |
B |
$0.86 |
$10,750 |
D/D |
12,500 |
12,500 |
2.74 |
- |
|
| Patel Mahesh V. |
CEO and President |
• • – |
2022-05-16 |
4 |
B |
$0.77 |
$38,495 |
D/D |
50,000 |
1,303,090 |
2.81 |
- |
|
| Patel Mahesh V. |
CEO and President |
• • – |
2021-11-18 |
4 |
B |
$1.09 |
$27,250 |
D/D |
25,000 |
1,253,090 |
2.81 |
- |
|
| Higuchi John W. |
Director |
– • – |
2020-12-31 |
4 |
S |
$1.35 |
$9,054 |
D/D |
(6,700) |
693,548 |
|
- |
|
| Hill Stephen A |
Director |
– • – |
2020-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
12,750 |
|
- |
|
| Higuchi John W. |
Director |
– • – |
2020-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
700,248 |
|
- |
|
| Ono Richard Dana |
Director |
– • – |
2020-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
10,125 |
|
- |
|
| Brown Morgan R |
EVP and CFO |
• – – |
2020-12-16 |
4 |
AS |
$1.35 |
$11,390 |
D/D |
(8,437) |
194,504 |
|
- |
|
| Brown Morgan R |
EVP and CFO |
• – – |
2020-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,125 |
202,941 |
|
- |
|
| Fink Jeffrey Arvin |
Director |
– • – |
2020-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,625 |
6,562 |
|
- |
|
| Patel Mahesh V. |
Chief Executive Officer |
• • – |
2020-12-16 |
4 |
AS |
$1.35 |
$20,250 |
D/D |
(15,000) |
1,228,090 |
|
- |
|
| Patel Mahesh V. |
Chief Executive Officer |
• • – |
2020-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,000 |
1,243,090 |
|
- |
|
| Patel Mahesh V. |
Chief Executive Officer |
• • – |
2020-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
122,978 |
1,198,090 |
|
- |
|
| Brown Morgan R |
Chief Financial Officer |
• – – |
2020-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
70,754 |
174,816 |
|
- |
|
| Patel Mahesh V. |
Chief Executive Officer |
• • – |
2020-12-04 |
4 |
AS |
$1.57 |
$68,134 |
D/D |
(43,500) |
1,075,112 |
|
- |
|
| Patel Mahesh V. |
Chief Executive Officer |
• • – |
2020-12-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
145,000 |
1,118,612 |
|
- |
|
51 Records found
|
|
Page 1 of 3 |
|
|
